iSpecimen (ISPC) Liabilities and Shareholders Equity: 2020-2025
Historic Liabilities and Shareholders Equity for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $9.0 million.
- iSpecimen's Liabilities and Shareholders Equity fell 20.12% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.2 million, marking a year-over-year decrease of 39.37%. This contributed to the annual value of $9.4 million for FY2024, which is 40.89% down from last year.
- According to the latest figures from Q3 2025, iSpecimen's Liabilities and Shareholders Equity is $9.0 million, which was up 49.10% from $6.0 million recorded in Q2 2025.
- iSpecimen's Liabilities and Shareholders Equity's 5-year high stood at $35.7 million during Q4 2021, with a 5-year trough of $6.0 million in Q2 2025.
- Over the past 3 years, iSpecimen's median Liabilities and Shareholders Equity value was $11.9 million (recorded in 2024), while the average stood at $12.6 million.
- As far as peak fluctuations go, iSpecimen's Liabilities and Shareholders Equity soared by 475.22% in 2021, and later plummeted by 49.30% in 2025.
- Quarterly analysis of 5 years shows iSpecimen's Liabilities and Shareholders Equity stood at $35.7 million in 2021, then crashed by 31.08% to $24.6 million in 2022, then tumbled by 35.74% to $15.8 million in 2023, then crashed by 40.89% to $9.4 million in 2024, then dropped by 20.12% to $9.0 million in 2025.
- Its Liabilities and Shareholders Equity was $9.0 million in Q3 2025, compared to $6.0 million in Q2 2025 and $6.8 million in Q1 2025.